Prime Medicine, Inc. (PRME) stock
PRMENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$4.27+0.38 (+9.77%)
Close on Nov 13, 2026Market cap $774.48MP/E –Yield –
Prime Medicine enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Prime Medicine's enterprise value was $682.07M on Nov 11, 2026, against $475.48M a year earlier. Over the last 5 years it ranged from $10.47M to $1.30B, with a median of $457.05M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $682.07M | +65.4% |
| 2025 | Dec 31, 2025 | $412.37M | +98.7% |
| 2024 | Dec 31, 2024 | $207.49M | -70.2% |
| 2023 | Dec 29, 2023 | $696.99M | +46.2% |
| 2022 | Dec 30, 2022 | $476.84M | – |
See a number that looks wrong?